According to a new market research study of “Middle East and Africa Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Analysis by Vaccine Type and Route Of Administration, Middle East and Africa typhoid fever vaccines market is projected to reach US$ 37.09 million in 2027 from US$ 20.00 million in 2019. The market is estimated to grow at CAGR of 8.3% from 2020 to 2027. The report highlights trends prevailing in the Middle East and Africa typhoid fever vaccines market and the factors driving market along with those that act as hindrances.
The typhoid fever vaccines market, based on vaccine type, is further segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. The capsular polysaccharide vaccines segment held the largest share of the market in 2019, whereas the live attenuated vaccine segment is anticipated to register the highest CAGR of in the market during the forecast period. Polysaccharide (PS) vaccines are antibacterial vaccines with unique characteristics and their main advantage is simplicity of production and high effectiveness against the bacteria.
Middle East and Africa typhoid fever vaccines market is expected to grow owing to growing initiatives for typhoid fever in Middle East and Africa region. However, risks associated with typhoid fever vaccines is likely to have a negative impact on the growth of the market in the coming years.
Leading companies operating in the Middle East and Africa typhoid fever vaccines market are includes GlaxoSmithKline plc, Shanghai institute of biological products co., ltd., Sanofi, Pax Vax Inc, BHARAT BIOTECH among others.
The report segments Middle East and Africa Typhoid Fever Vaccines market as follows:
By Vaccine Type
By Route of Administration
By Country
Reasons to Buy
The typhoid fever vaccines market, based on vaccine type, is further segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. The capsular polysaccharide vaccines segment held the largest share of the market in 2019, whereas the live attenuated vaccine segment is anticipated to register the highest CAGR of in the market during the forecast period. Polysaccharide (PS) vaccines are antibacterial vaccines with unique characteristics and their main advantage is simplicity of production and high effectiveness against the bacteria.
Middle East and Africa typhoid fever vaccines market is expected to grow owing to growing initiatives for typhoid fever in Middle East and Africa region. However, risks associated with typhoid fever vaccines is likely to have a negative impact on the growth of the market in the coming years.
Leading companies operating in the Middle East and Africa typhoid fever vaccines market are includes GlaxoSmithKline plc, Shanghai institute of biological products co., ltd., Sanofi, Pax Vax Inc, BHARAT BIOTECH among others.
The report segments Middle East and Africa Typhoid Fever Vaccines market as follows:
By Vaccine Type
- Live Attenuated Vaccine
- Capsular Polysaccharide Vaccines
- Conjugate Vaccine
- Others
By Route of Administration
- Oral
- Injectable
By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East and Africa
Reasons to Buy
- To understand the Middle East and Africa typhoid fever vaccines market landscape and identify market segments that are most likely to guarantee a strong return.
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Middle East and Africa typhoid fever vaccines market.
- Efficiently plan M&A and partnership deals in Middle East and Africa typhoid fever vaccines market by identifying market segments with the most promising probable sales.
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments from Middle East and Africa typhoid fever vaccines market.
- Obtain market revenue forecast for market by various segments from 2019-2027 in Middle East and Africa.
Table of Contents
1. Introduction
3. Research Methodology
4. Middle East and Africa Typhoid Fever Vaccines Market Landscape
5. Middle East and Africa Typhoid Fever Vaccines Market Key Market Dynamics
6. Typhoid Fever Vaccines Market - Middle East and Africa Analysis
7. Typhoid Fever Vaccines Market - by Vaccine Type
8. Typhoid Fever Vaccines Market Analysis - by Route of Administration
9. Typhoid Fever Vaccines Market Revenue and Forecasts to 2027 - Geographical Analysis
10. Impact of COVID-19 Pandemic on Global Typhoid Fever Vaccines Market
11. Company Profiles
12. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- GlaxoSmithKline plc
- Shanghai institute of biological products co. ltd.
- Sanofi
- Pax Vax Inc
- BHARAT BIOTECH
